Calls for papers
-
Nasal drug delivery specialist Kurve Technology announced that the US Department of Defense (DoD) has awarded the company a contract for testing a formulation for the treatment of traumatic brain injury (TBI). The Kurve ViaNase… Read more . . .
-
Submit 500-word poster abstracts by August 31 at http://inhalationasia.org/conference/inhalation-asia-19/present Please note that according to the organizers, “ALL authors agree to make their abstracts and a copy of their poster or presentation available for free to… Read more . . .
-
DPI developer TFF Pharmaceuticals said that is has raised $8.17 million through a Series A preferred stock offering and that it will use the funds for R&D. In April 2018, the company announced that it… Read more . . .
-
Acerus Pharmaceuticals said that it has acquired exclusive worldwide rights to technology related to intranasal delivery of testosterone from the University of Texas at Austin. The company said that the agreement covers the use of… Read more . . .
-
According to BlueWillow Biologics, the University of Michigan has been issued US patent No. 10,138,279 which covers an intranasal anthrax vaccine formulated with BlueWillow’s NanoVax adjuvant. BlueWillow (formerly NanoBio) is a spin out from the University… Read more . . .
-
Nanonization company Nanoform has named former Hovione Senior Project Manager Miguel Cansado as Director of Project Management. Cansado is the third former Hovione employee to join Nanoform this year, following the appointments of Miguel Calado… Read more . . .
-
CDMO Particle Sciences is now registered with the US Drug Enforcement Administration (DEA) as a manufacturer of Schedule I substances, which means that the company can now provide development and manufacturing services for pharmaceutical cannabinoid… Read more . . .
-
Proveris Scientific has announced the availability of new testing services that “support the FDA’s newly released draft guidance on beclomethasone dipropionate that promotes alternate in-vitro studies in lieu of clinical endpoint.” According to Proveris, the… Read more . . .
-
Insmed Incorporated said that a just-closed public stock offering generated net proceeds of about $235.5 million that will be used for continuing commercialization of Arikayce amikacin liposome inhalation suspension (ALIS). The offering of 9,615,385 shares of… Read more . . .
-
Inhalation Sciences (ISAB) has announced that it will divest 40,000 shares of its subsidiary Ziccum AB in order to finance a study to validate its PreciseInhale dosing system for clinical use. The company said that… Read more . . .
Upcoming Events
Sponsored by Intertek
Want information about upcoming OINDP-related events delivered directly to your inbox? click here
October 19-October 20: MVIC Autumn Training 2026, Lund, Sweden
October 21-October 22: MVIC Symposium, Lund, Sweden
November 10-November 11: Rescon Europe 2026, Porto, Portugal
December 9-December 11: DDL 2026, Edinburgh, Scotland